Abstract
However, few new therapies have been advanced in recent years. The outlook for treatment with surgery alone or combined with chemotherapy is also poor, with typical survival of about three and six months, respectively. Literature reviews, retrospective studies reporting on overall survival and studies on molecular aspects of HEC have been performed in the last few past years. These resear…